A detailed history of Lido Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Lido Advisors, LLC holds 6,064 shares of CORT stock, worth $445,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,064
Previous 5,601 8.27%
Holding current value
$445,522
Previous $639,000 30.36%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$62.24 - $91.93 $28,817 - $42,563
463 Added 8.27%
6,064 $445,000
Q1 2025

May 15, 2025

BUY
$49.85 - $114.22 $279,209 - $639,746
5,601 New
5,601 $639,000
Q2 2023

Aug 09, 2023

SELL
$21.44 - $25.15 $145,984 - $171,246
-6,809 Reduced 29.59%
16,199 $360,000
Q1 2023

May 15, 2023

BUY
$19.2 - $24.47 $441,753 - $563,005
23,008 New
23,008 $498,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.87B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.